116764-15-9
Product Name:
AVENANTHRAMIDEC
Formula:
C16H13NO6
Synonyms:
N-[3′,4′-Dihydroxy-(E)-cinnamoyl]-5-hydroxyanthranilic acid;2-{[(2E)-3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]amino}-5-hydroxybenzoic acid;Avenanthramide Bc
Inquiry
SAFETY INFORMATION
| Signal word | Warning |
|---|---|
| Pictogram(s) |
 Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H302:Acute toxicity,oral |
COMPUTED DESCRIPTORS
| Molecular Weight | 315.28 g/mol |
|---|---|
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | 315.07428713 g/mol |
| Monoisotopic Mass | 315.07428713 g/mol |
| Topological Polar Surface Area | 127 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 466 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
2-{[(2E)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-hydroxybenzoic acid is an alkaloid and a member of benzamides.